Standout Papers
Citation Impact
Citing Papers
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
2010 StandoutScience
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry
1998 StandoutNobel
CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro
2000
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
Correlates of protection in HIV infection and the progression of HIV infection to AIDS
1996
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission in HIV‐1–Discordant Partners
2000
Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac Transplantation
1990
Protection against Human Immunodeficiency Virus Type 1 Infection in Persons with Repeated Exposure: Evidence for T Cell Immunity in the Absence of Inherited CCR5 Coreceptor Defects
1999
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells
2004
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Human α Defensin in HIV-Exposed But Uninfected Individuals
2004
Immune responses in HIV-exposed seronegatives: have they repelled the virus?
1995
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures
1996
Influence of HLA Supertypes on Susceptibility and Resistance to Human Immunodeficiency Virus Type 1 Infection
2000
Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure
2002
Human Immunodeficiency Virus (HIV)–Specific Cytotoxic T Lymphocyte Activity in HIV‐Exposed Seronegative Persons
1999
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
1998 StandoutNobel
Expression and Functional Characterization of Mutant Human CXCR4 in Insect Cells: Role of Cysteinyl and Negatively Charged Residues in Ligand Binding
2000
Emtricitabine
2003
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Transfusion Medicine — Blood Transfusion
1999 Standout
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Association of Polymorphisms in Human Leukocyte Antigen Class I and Transporter Associated with Antigen Processing Genes with Resistance to Human Immunodeficiency Virus Type 1 Infection
2003
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
1995
Emtricitabine (FTC) for the treatment of HIV infection
2004
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
1998 StandoutNobel
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
2006 StandoutNobel
Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure
1999
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
1999
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors
1996 Standout
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam
2003 StandoutNobel
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
2004
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients
2005
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
1995
Emtricitabine
2005
Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand
1999
Protective immunity against HIV infection: has nature done the experiment for us?
1996
Inclusion body myositis with human immunodeficiency virus infection: Four cases with clonal expansion of viral‐specific T cells
2007
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Serological and virological characterization of HIV-1 group O infection in Cameroon
1997 StandoutNobel
HIV Drug Resistance
2004
Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle
1992
HIV as the cause of AIDS
1996 StandoutNobel
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
2001
Hepatitis C Virus‐Specific Cytolytic T Lymphocyte and T Helper Cell Responses in Seronegative Persons
1997 StandoutNobel
Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus
2005
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men
2003
New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia
2004 StandoutNobel
Long-term survivors of HIV-1 infection
1995
Autoantibodies to CD4 in HIV Type 1-Exposed Seronegative Individuals
1996
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity
2000
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Cohabitation of Leishmania amazonensis and Coxiella burnetii
1996
Towards improvements in molecular tools for diagnosis and management of HIV infections
1999 StandoutNobel
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
1993 Standout
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
1997
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
1996 StandoutNature
Polymyositis and dermatomyositis
2003 Standout
Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal lymphoma study group
1989
HIV-1 infectability of CD4+ lymphocytes with relation to β-chemokines and the CCR5 coreceptor
1999
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection
1995
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
1994 Standout
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Entry and survival of Leishmania amazonensis amastigotes within phagolysosome-like vacuoles that shelter Coxiella burnetii in Chinese hamster ovary cells
1995
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals
1996
Human microsporidial infections
1994 Standout
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Inflammatory Muscle Diseases
2015 Standout
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy
2004
Etiology and evaluation of diarrhea in AIDS:a global perspective at the millennium.
2000
Short- and Long-Term Clinical Outcomes in Rhesus Monkeys Inoculated with a Highly Pathogenic Chimeric Simian/Human Immunodeficiency Virus
2000
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Cell surface receptors, virus entry and tropism of primate lentiviruses
2002
Effect of Mutations in the Second Extracellular Loop of CXCR4 on Its Utilization by Human and Feline Immunodeficiency Viruses
1999
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
Pathogenesis of human immunodeficiency virus infection
1993
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors
1996 StandoutNobel
Lack of infection in HIV-exposed individuals is associated with a strong CD8+cell noncytotoxic anti-HIV response
1999
Antiretroviral effect of zidovudine–didanosine combination on blood and lymph nodes
1997
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection
1996 Science
Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells
2003
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
1996 StandoutScience
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
HIV VACCINES
2005
Human immunodeficiency virus‐1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus
2001
Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii
2007 Standout
HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi
2000
Chemokine receptors and human immunodeficiency virus infection
1998
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of F Ferchal being referenced
HIV-1 sensitivity to zidovudine: A consensus culture technique validated by genotypic analysis of the reverse transcriptase
1992
Intestinal Microsporidiosis in Human Immunodeficiency Virus-Infected Patients with Chronic Unexplained Diarrhea: Prevalence and Clinical and Biologic Features
1993
Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients
2000
Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
1994
Adult T-cell leukemia associated with HTLV-I and simultaneous infection by human immunodeficiency virus type 2 and human herpesvirus 6 in an African woman: A clinical, virologic, and familial serologic study
1988 StandoutNobel
Comparative Assessment of Quantitative HIV Viraemia Assays
1992
Comparison of Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Stavudine and Didanosine or Zidovudine and Lamivudine
2001
Interaction between human immunodeficiency virus and Toxoplasma gondii replication in dually infected monocytoid cells
1993
Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
1997
Inclusion‐body myositis: Clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen
1982
[The bacterial agent of cat-scratch disease].
1987
[Bacteriological, parasitological and virological study of the digestive flora in alpha-chain disease].
1985